Pay in 4 interest-free payments of $6.53 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The SURMOUNT-1 trial, which evaluated tirzepatide specifically for weight management in patients with obesity, demonstrated even more impressive results: average weight reductions of 15% (10 mg dose) to 20.9% (15 mg dose) of initial body weight over 72 weeks
Here are key points to consider: 1
This gradual increase minimizes nausea (reported in 20-30% of patients) while building tolerance
doi:10.1016/S0003-2697(03)00143-X
US$ 26.54
US$ 21.70
US$ 24.45
US$ 27.69
US$ 24.43
US$ 26.85
US$ 20.05
